Balanced news tone
News Sentiment
4577 sentiment intelligence
Daito Pharmaceutical Co.,Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
62/100 classification confidence.
directly relevant articles
high-authority source matches
+0.3% over one week, +3.4% over four weeks, trend inactive, and near fair-value range.
Daito Pharmaceutical Completes ¥605 Million Share Buyback to Boost Capital Efficiency
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Daito Pharmaceutical Completes ¥605 Million Share Buyback to Boost Capital Efficiency
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 13 Jul 2026 02:28
- Source
- TipRanks
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 500,000 shares, representing 1.73% for ¥625 million.
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 10 Jul 2026 15:42
- Source
- marketscreener.com
Daito Pharmaceutical Overhauls Board and Executive Structure to Bolster Governance and Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 07:54
- Source
- TipRanks
ETFs Investing in Daito Pharmaceutical Co., Ltd. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 01:02
- Source
- TradingView
Price to earnings forward of Daito Pharmaceutical Co., Ltd. – TSE:4577
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 02:18
- Source
- TradingView